Showing results (21-30 of 247) with videos related to

Sort By:
Pageof 25
International Journal of Molecular Sciences|September 6, 2018
Heterogeneity of γH2AX Foci Increases in Ex Vivo Biopsies Relative to In Vivo TumorsTreewut Rassamegevanon, Steffen Löck, Michael Baumann, et al.
Radiation Oncology (London, England)|December 23, 2011
Radiotherapy and "new" drugs-new side effects?Maximilian Niyazi, Cornelius Maihoefer, Mechthild Krause, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 29, 2025
Development of a model to guide the decision for radiotherapy in deep-inspiration breath-hold in patients with left-sided breast cancerAnnett Linge, Carina Ketzmerick, Kristin Gurtner, et al.
Radiation Oncology (London, England)|February 19, 2014
Establishment of a small animal tumour model for in vivo studies with low energy laser accelerated particlesKerstin Brüchner, Elke Beyreuther, Michael Baumann, et al.
Radiation Oncology (London, England)|August 16, 2015
Impact of waiting time after surgery and overall time of postoperative radiochemotherapy on treatment outcome in glioblastoma multiformeAnnekatrin Seidlitz, Timo Siepmann, Steffen Löck, et al.
Plos One|May 26, 2017
An optimized small animal tumour model for experimentation with low energy protonsElke Beyreuther, Kerstin Brüchner, Mechthild Krause, et al.
Molecular Oncology|March 17, 2020
Specific requirements for translation of biological research into clinical radiation oncologyMechthild Krause, Jan Alsner, Annett Linge, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 9, 2011
Residual DNA double strand breaks in perfused but not in unperfused areas determine different radiosensitivity of tumoursApostolos Menegakis, Wolfgang Eicheler, Ala Yaromina, et al.
Acta Oncologica (Stockholm, Sweden)|August 30, 2017
Modeling in vivo relative biological effectiveness in particle therapy for clinically relevant endpointsArmin Lühr, Cläre von Neubeck, Stephan Helmbrecht, et al.
Pharmaceuticals (Basel, Switzerland)|March 8, 2014
Radiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and TherapyWiebke Sihver, Jens Pietzsch, Mechthild Krause, et al.
Pageof 25